Following a quarter in which sales of its sera products declined sharply, Invitrogen officials said last week that they are reviewing the firm’s entire portfolio with a particular focus on the sera business.
 
Additionally, though the officials declined to say whether a divestment of that business was possible, Chairman and CEO Greg Lucier said the firm is currently reviewing whether “we need to be broadly in the sera business” and hopes to know more in six months.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.